[Treatment for acute promyelocytic leukemia]

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Arsenic Trioxide
• Arsenicals / administration & dosage*
• Benzoates / administration & dosage*
• Clinical Trials, Phase III as Topic
• Consolidation Chemotherapy
• Disseminated Intravascular Coagulation / etiology
• Disseminated Intravascular Coagulation / prevention & control
• Gene Fusion
• Humans
• Induction Chemotherapy
• Leukemia, Promyelocytic, Acute / complications
• Leukemia, Promyelocytic, Acute / drug therapy*
• Leukemia, Promyelocytic, Acute / genetics*
• Maintenance Chemotherapy
• Molecular Targeted Therapy*
• Nuclear Proteins / genetics
• Oxides / administration & dosage*
• Promyelocytic Leukemia Protein
• Receptors, Retinoic Acid / genetics
• Recurrence
• Remission Induction
• Retinoic Acid Receptor alpha
• Tetrahydronaphthalenes / administration & dosage*
• Transcription Factors / genetics
• Tretinoin / administration & dosage*
• Tumor Suppressor Proteins / genetics